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Abstract Central cholinergic dysfunction contributes to acute
spatial memory deficits produced by ethanol administration.
Donepezil and rivastigmine elevate acetylcholine levels in the
synaptic cleft through the inhibition of cholinesterases—en-
zymes involved in acetylcholine degradation. The aim of our
study was to reveal whether donepezil (acetylcholinesterase
inhibitor) and rivastigmine (also butyrylcholinesterase inhibi-
tor) attenuate spatial memory impairment as induced by acute
ethanol administration in the Barnes maze task (primary laten-
cy and number of errors in finding the escape box) in rats.
Additionally, we compared the influence of these drugs on
ethanol-disturbed memory. In the first experiment, the dose of
ethanol (1.75 g/kg, i.p.) was selected that impaired spatial
memory, but did not induce motor impairment. Next, we stud-
ied the influence of donepezil (1 and 3 mg/kg, i.p.), as well as
rivastigmine (0.5 and 1 mg/kg, i.p.), given either before the
probe trial or the reversal learning on ethanol-induced memory
impairment. Our study demonstrated that these drugs, when
given before the probe trial, were equally effective in attenuat-
ing ethanol-induced impairment in both test situations, whereas
rivastigmine, at both doses (0.5 and 1 mg/kg, i.p.), and
donepezil only at a higher dose (3 mg/kg, i.p.) given prior the
reversal learning, attenuated the ethanol-induced impairment in
cognitive flexibility. Thus, rivastigmine appears to exert more
beneficial effect than donepezil in reversing ethanol-induced
cognitive impairments—probably due to its wider spectrum
of activity. In conclusion, the ethanol-induced spatial memory
impairment may be attenuated by pharmacological manipula-
tion of central cholinergic neurotransmission.
Keywords Barnesmaze . Spatial memory . Ethanol .
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Introduction
Ethanol is one of the most frequently abused drugs in our
society, and there is a widespread agreement that acute ethanol
intoxication affects memory and attention in humans
(Goodwin et al. 1970; Tharp et al. 1974; Weissenborn and
Duka 2000). In laboratory animals, acute intraperitoneal eth-
anol administration selectively impairs the spatial memory
(Berry and Matthews 2004; Matthews et al. 1995; Matthews
et al. 1999) which is necessary to accurately navigate within
the environment (Brazhnik et al. 2003; Mehta 2015). It has
been demonstrated that ethanol and hippocampal system
damage produce similar patterns of learning and memory
impairment (Matthews et al. 1996; Ryabinin 1998).
Cholinergic projections of the basal forebrain/nucleus
basalis magnocellularis and medial septum (basal forebrain
cholinergic complex) to the cerebral cortex and hippocampus
have long been regarded as critical for memory (Bartus et al.
1985; Schliebs and Arendt 2011; Teles-Grilo Ruivo and
Mellor 2013). Some studies have reported that the reduction
in hippocampal acetylcholine (ACh) levels (either natural due
to aging or pharmacological) specifically correlates with im-
pairment in spatial memory (Ikegami 1994; Mishima et al.
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2000; Gold 2003). Interestingly, acute systemic ethanol exerts
a biphasic effect on ACh release in the hippocampus: appar-
ently, low doses (0.8 g/kg) increase hippocampal ACh release,
by a direct effect on the septohippocampal pathway, while a
sedative dose (2.4 g/kg) reduces ACh release (Henn et al.
1998). This inhibitory effect may be responsible for the
well-known cognitive effects of acute ethanol administration,
such as learning impairment and amnesia. However, correla-
tion between the behavioral effects of low ethanol dose and
hippocampal ACh release is less understood (Stancampiano
et al. 2004).
Another brain region that receives cholinergic projection
from the nucleus basalis magnocellularis is the prefrontal
cortex (PFC) (Mesulam et al. 1983). Several studies have
demonstrated that interactions between the PFC and hippocam-
pus are involved in spatial memory (Lee and Kesner 2003; Kyd
and Bilkey 2003; Wang and Cai 2006). However, the PFC
incorporates several distinct areas of the frontal cortex that
are associated with processes involved in executive functions,
including working memory, attention, cognitive flexibility, and
impulse control (Logue and Gould 2014). These complex
behaviors allow for adaptation in response to changes in the
environment and are modulated by various neurotransmitters,
including the cholinergic system (Logue and Gould 2014).
Acute ethanol injection shows a dose-dependent effect on
ACh release in PFC (Stancampiano et al. 2004): low intraper-
itoneal doses of ethanol (0.5 g/kg) increase, while higher doses
(1 g/kg) reduce ACh release in the rat PFC (Stancampiano et al.
2004; Jamal et al. 2010). These biphasic changes of ACh trans-
mission in the PFC may be of relevance for the bidirectional
modulation of working memory by ethanol (Rossetti et al.
2002; Stancampiano et al. 2004).
In the mammalian brain, synaptic levels of ACh are regu-
lated by two types of cholinesterases: acetylcholinesterase and
butyrylcholinesterase that inactivate ACh (Giacobini 2004;
Ballard et al. 2005). Treatment with cholinesterase inhibitors
increases ACh level. Donepezil is a centrally acting, reversible
acetylcholinesterase inhibitor (Dooley and Lamb 2000; Liston
et al. 2004), while rivastigmine is a highly potent agent that
blocks both acetylcholinesterase and butyrylcholinesterase
(Ogura et al. 2000; Racchi et al. 2004). These drugs are ap-
proved by the US Food and Drug Administration (FDA) as a
first-choice therapy for the treatment of mild to moderate
Alzheimer’s disease (Zemek et al. 2014).) It should be noted
that disturbances in the cholinergic system as well as spatial
memory impairments are observed in Alzheimer’s disease and
after chronic ethanol treatment (Adelstein et al 1992; Arendt
et al. 1988, b; Bartus et al. 1982; Monacelli et al. 2003).
The aim of the present study was to examine whether the
cholinesterase inhibitors, donepezil and rivastigmine, are ca-
pable of modifying short-term spatial memory and cognitive
flexibility (reversal learning) impairments caused by acute
ethanol administration in the Barnes maze task in rats. The
task is based on the assumption that the animal should learn
and remember the location of a safe shelter (Carrillo-Mora
et al. 2009), and the test consists of several phases. These
include a habituation phase, in which the animals are intro-
duced to the environment and task, and the acquisition phase
(training), during which the animals learn to find the location
of the shelter. These are followed by a test consisting of two
parts. The first part of the test (called the Bprobe trial^) is
carried out with the unchanged position of the shelter in rela-
tion to the acquisition sessions—this allows an assessment of
spatial memory retention, which is a subset of the short-term
memory (24 h after the training sessions) required to perform
certain operations (Carrillo-Mora et al. 2009; Cowan 2008;
Brickman and Stern 2009). In turn, the second part of the test
(called Breversal learning^), by changing the target position,
allows for the assessment of cognitive flexibility necessary to
relearn a new location that is no longer rewarded (Carrillo-
Mora et al. 2009). The advantage of the Barnes maze task as
compared to other animal models is the elimination of highly
stressful stimulus (e.g., water).
Furthermore, in the current experiments, we compared the
influence of donepezil, which functions solely as a pharmaco-
logical inhibitor of acetylcholinesterase, and rivastigmine,
which also acts as a butyrylcholinesterase inhibitor (Dooley
and Lamb 2000; Liston et al. 2004; Ogura et al. 2000; Racchi
et al. 2004), on acute ethanol-induced impairment in the
spatial memory and cognitive flexibility in the Barnes maze
task. In the first experiment, the dose of ethanol that impaired
spatial memory, but did not induce motor impairment, was
selected. Such dose was used in further studies. In our study,
we expected stronger beneficial effects of rivastigmine on the
improvement of ethanol-induced memory deficiency, due to a
wider spectrum of activity, as compared to donepezil.
Materials and methods
Animals and drugs
Male Wistar rats (HZL, Warsaw, Poland), weighing 200–
250 g at the beginning of the experiment, were habituated
for at least 1 week before the experiment. The animals were
maintained under the standard laboratory conditions (22 °C,
12:12 light/dark cycle) and housed ten per cage with food
(Agropol, Motycz, Poland) and water available ad libitum.
A total of 292 animals were used. All behavioral studies were
performed between 09:00 and 17:00. All experimental proto-
cols and housing conditions were approved by the Local
Ethics Committee and carried out according to the National
Institute of Health Guidelines for the Care and Use of
Laboratory Animals and the European Community Council
Directive of November 2010 for Care and Use of Laboratory
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Animals (Directive 2010/63/EU) and were approved by the
Local Ethics Committee.
The following drugs were used: ethanol (95 %,
POCH, Gliwice, Poland) was mixed with 0.9 % NaCl
(saline) to make 10 % w/v solution and was adminis-
tered by intraperitoneal (i.p.) injection. Donepezil hydro-
chloride (Sigma-Aldrich, St. Louis, MO, USA) and
rivastigmine (Sigma-Aldrich, St. Louis, MO, USA) were
dissolved in saline and injected in a volume of 2 ml/kg,
i.p. Control groups received saline injections in the
same volume and by the same route.
Barnes maze task
The Barnes maze (Stoelting, Dublin, Ireland) consisted of a
gray metal, circular platform of 122 cm diameter, elevated
90 cm above the floor, with 20 equally spaced holes (10 cm
diameter) located in the periphery. One of the holes was
connected to an escape box of 35 cm × 12 cm × 12 cm, of the
same material and color as the platform. The other holes were
covered underneath with a flat box, also of the same material
and color. From the center of the maze, all holes looked iden-
tical, so that the rats could not discriminate the escape hole
from other holes until situated adjacent to it. Numerous visual
cues (in the form of large colorful geometric shapes) were
placed on the walls of the testing room at 1–2 m distance from
the edge of the maze. To further evoke the potentiated escape
response, the platform was brightly lit (two points of light
1.5 m above the maze; 500 Weach) and a buzzer placed above
the center of the maze provided a sound of 80 dB as an
additional aversive stimulus to provoke the escape from the
platform.
The Barnes maze task was carried out according to the
method described by Kuzmin et al. (2012) with minor
modifications. The Barnes maze task consisted of the
following phases: (i) adaptation phase (habituation); (ii)
acquisition phase; and (iii) test phase (probe trial and
reversal learning).
Habituation One day before the acquisition phase, the rats
were habituated to the platform and the escape box to reduce
anxiety behavior. This habituation trial was performed with
the lights on, but without the buzzer sound.
Acquisition phase The acquisition phase began 24 h after the
maze habituation. Acquisition involved one training session
per day for 4 consecutive days. Each training session
consisted of three 180-s trials, with 10-min inter-trial interval
during which animals returned to their home cage. The loca-
tion of the platform and the escape box remained constant
over all the acquisition trials. Each trial began by placing the
animal at the center of the platform, the buzzer was excited,
and rats were allowed to freely explore the apparatus. The trial
was completed after 180 s or when the animal entered the
escape box. Immediately after entering the escape box, the
buzzer was turned off and the hole was covered for 30 s before
the rat was returned to home cage. If the animal did not enter
the goal box within 180 s, it was gently guided there by the
experimenter and could explore it for 30 s. To eliminate olfac-
tory cues, the platform surface and the goal box were wiped
with a 10 % (w/v) ethanol solution after each trial to dissipate
odor cues and provide a standard olfactory context for each
trial. All trials were recorded by a trained observer. Since the
animals occasionally lacked motivation and merely explored
the maze after finding the escape box without entering into it,
following the work of many authors (Harrison et al. 2006; Li
et al. 2014; Patil et al. 2009), in our experiments, we scored
such parameters as the primary latency and primary errors.
Primary latency was defined as the time required for the rat
to make initial contact with the escape box. Primary errors
were defined as the number of holes visited before the first
contact with the escape box.
Probe trialOne day after the acquisition phase (i.e., on day 5),
the subjects received a probe trial for 90 s to evaluate spatial
memory. During this trial, the tunnel leading to the escape box
was closed (Li et al. 2014; Patil et al. 2009). The rats were
allowed to explore the maze and investigate the escape box
and the adjacent holes. The primary latency and primary errors
to reach the escape box were counted.
Reversal learning One hour after completion of the probe
trial, three 180-s reversal learning trials were conducted.
Reversal learning trials were identical to the acquisition trials,
except that the position of the escape hole was rotated 180°.
The rat was, therefore, unable to escape the maze using the
acquired spatial cues, but had to relearn the new location of the
hole. Data obtained from the reversal learning trials were
pooled together and used for calculations of primary latency
and primary errors.
Locomotor activity
The locomotor activity of individual rats was recorded using a
photocell apparatus (Porfex, Bialystok, Poland). The animals
were individually placed in Plexiglas boxes (square cages,
60 cm a side) in a sound-attenuated experimental room. The
cages were equipped with two rows of infrared, light-sensitive
photocells, located 40 and 100 mm above the floor.
Locomotor activity was recorded as a horizontal activity
(distance traveled) by each rat for a total period of 15 min.
Rotarod performance test
Rats were tested in the rotarod apparatus (Multiserv,
Lublin, Poland), similarly to the method described
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previously (Kotlinska et al. 2012). On the day preceding
the experiment, all rats were accustomed to the apparatus
(6 cm in diameter, 50 cm in length, subdivided into four
areas by the disks, 25 cm in diameter, at a constant rotat-
ing speed of 9 rpm) in order to evaluate their perfor-
mance. The time from the moment when the rod began
to rotate until the rat fell off from it was measured (reten-
tion time). The rats that held onto the rotating rod for at
least 2 min were selected for further experiments. In order
to reveal the influence of acute ethanol or cholinesterase
inhibitors on motor coordination, the latency of falling off
the rotarod was determined 30 min after ethanol and
50 min after donepezil (1 or 3 mg/kg) or rivastigmine
(0.5 or 1 mg/kg) administration. The animals that did
not fall off the rotarod within 1 min were given the max-
imum score of 60 s.
Experiment 1 Effect of acute ethanol administration before
the probe trial on spatial memory retrieval, locomotor activity,
and motor coordination in rats
The animals (n = 28) were trained in the Barnes maze task
for 4 consecutive days with one session per day. Such sessions
consisted of three trials separated by a 10-min inter-trial
interval (acquisition phase), as described above (Fig. 1a).
The animals were then randomly assigned to the one of four
treatment groups (n = 7 per group) and subjected to the probe
trial on the 5th day, 24 h after the last acquisition trials. One
group received ethanol at the dose of 1.5 g/kg, the second
group received 1.75 g/kg ethanol, the third group received
2.0 g/kg ethanol, and the fourth group received saline.
Ethanol (10 % w/v) and saline were administered 30 min be-
fore the probe trial on the test day. Immediately after the probe


























Fig. 1 Diagram of the experimental design. a Effect of acute ethanol
administration before the probe trial on spatial memory retrieval,
locomotor activity, and motor coordination in rats. b Effect of donepezil/
rivastigmine, given before the probe trial on spatial memory retrieval and
cognitive flexibility, impaired by acute ethanol administration in Barnes
maze task. c Effects of cholinesterase inhibitors, given before the reversal
learning, on cognitive flexibility, impaired by acute ethanol administration
before the probe trial in the Barnes maze task
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activity (locomotor activity cages) and the motor coordination
(rotarod test) was assessed to exclude the influence of these
ethanol doses on locomotor disturbances so as to exclude
nonspecific effects in the memory task. On the basis of these
experiments, the dose of ethanol of 1.75 g/kg was selected for
further studies.
Experiment 2 Effect of donepezil, given before the probe trial,
on spatial memory retrieval and cognitive flexibility impaired
by acute ethanol administration in the Barnes maze task
During the acquisition phase, rats received three trials per
day for 4 consecutive days (Fig. 1b). The probe trial was given
on the 5th day, 24 h after the last acquisition trial. Before the
probe trial, the animals (n = 82) were placed into six groups:
saline + saline; saline + ethanol (1.75 g/kg); donepezil
(1 mg/kg) + saline; donepezil (3 mg/kg) + saline; donepezil
(1 mg/kg) + ethanol (1.75 g/kg); and donepezil (3 mg/kg) +
ethanol (1.75 g/kg) (n = 13–14 per group). The doses of the
donepezil (Gawel et al. 2014) and the dose of ethanol (exper-
iment 1) were chosen based on our previous experiments.
Fifty minutes and 30 min prior to the probe trial, the rats
received donepezil and ethanol (1.75 g/kg) or saline, re-
spectively, whereas the control group received saline in-
stead of either the cholinesterase inhibitors or ethanol.
One hour after the completion of the probe trial, three
180-s reversal learning trials were conducted, according
to the procedure described above.
Experiment 3 Effect of rivastigmine, given before the probe
trial on spatial memory retrieval and cognitive flexibility im-
paired by acute ethanol administration in the Barnes maze task
Rats were trained in the Barnes maze for 4 consecutive
days (acquisition phase), with three trials per day (Fig. 1b).
The probe trial was given on the 5th day, 24 h after the last
acquisition trial. Before the probe trial, the animals (n = 72)
were placed into six groups: saline + saline; saline + ethanol
(1.75 g/kg); rivastigmine (0.5 mg/kg) + saline; rivastigmine
(1 mg/kg) + saline; rivastigmine (0.5 mg/kg) + ethanol
(1.75 g/kg); and rivastigmine (1 mg/kg) + ethanol (1.75 g/kg)
(n = 12 per group). The doses of rivastigmine (Gawel et al.
2014) were chosen based on our previous experiment.
Fifty minutes and 30 min prior to the probe trial, the rats
received rivastigmine and ethanol (1.75 g/kg) or saline,
respectively, whereas the control group received saline
instead of either the cholinesterase inhibitors or ethanol.
One hour after the completion of the probe trial, three
180-s reversal learning trials were conducted, according
to the procedure described above.
Experiment 4 Effects of cholinesterase inhibitors, given be-
fore the reversal learning, on cognitive flexibility impaired by
acute ethanol administration before the probe trial in the
Barnes maze task
During the acquisition phase, the rats were trained in
the Barnes maze for 4 days, with three trials per day, as
described above (Fig. 1c). Then, on the 5th day, the ani-
mals (n = 72) were randomly placed into six groups: sa-
line + saline; ethanol (1.75 g/kg) + saline; ethanol
(1.75 g/kg) + donepezil (1 mg/kg); ethanol (1.75 g/kg) +
donepezil (3 mg/kg); ethanol (1.75 g/kg) + rivastigmine
(0.5 mg/kg); and ethanol (1.75 g/kg) + rivastigmine
(1 mg/kg) (n = 12 per group). Ethanol was given 30 min
before the probe trial, while donepezil or rivastigmine was
given 10 min after the probe trial (50 min before the
reversal learning trials).
Experiment 5 Effect of acute donepezil and rivastigmine on
locomotor activity and motor coordination in rats
The new cohort of animals (n = 38) was placed into five
groups: saline, donepezil (1 mg/kg), donepezil (3 mg/kg),
rivastigmine (0.5 mg/kg), and rivastigmine (1 mg/kg) (n = 7
per group). Fifty minutes after saline/donepezil/rivastigmine
administration, the locomotor activity test, followed by the
rotarod test, was performed (Figs. 2 and 3).
Statistical analysis
Data from experiments 1, 4, and 5 were statistically analyzed
by one-way analysis of variance (ANOVA), followed by the
Tukey-Kramer post hoc test (Figs. 1 and 4). Data from exper-
iments 2 and 3 were analyzed using two-way analysis of
variance (ANOVA) with the factors Btreatment^ (between
subjects) and Bdose of donepezil/rivastigmine^ (within sub-
jects), followed by the Bonferroni post hoc test (Figs. 2 and 3).
Results were presented as mean ± standard errors (SEM).
P value less than 0.5 was considered statistically significant
for all tests.
Results
Experiment 1 Effect of acute ethanol (1.5, 1.75, 2 g/kg)
administration before the probe trial on spatial memory
retrieval in the Barnes maze, locomotor activity, and motor
coordination in rats
On the last day of acquisition (4th day, 1 day before random-
ization), the average latency (basal primary latency) in rats to
reach the escape box (mean of three trials ± SEM) was 15.64 s
± 1.56 s.
On day 5, animals’ spatial memory was evaluated by the
probe trial. A one-way ANOVA showed significant treatment
effect on the primary latency [F(3,25) = 13.84; P < 0.001,
Fig. 2a] and number of errors [F(3, 25) = 5.94; P < 0.01,
Fig. 2b]. Unlike controls, ethanol-treated rats required more
time (primary latency) to find the escape box at the doses of
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1.5 (P < 0.05), 1.75 (P < 0.01), or 2 g/kg (P < 0.001) and
showed a statistically significant increase in the number of
primary errors to reach the escape box at the doses of 1.5
(P < 0.05), 1.75 (P < 0.01), or 2 g/kg (P < 0.05). A one-way
ANOVA showed that there was significant effect of the treat-
ment on the locomotor activity [F(3,25) = 6.08, P < 0.05,
Fig 2c] and coordination [F(3,25) = 48.45, P < 0.001,
Fig. 2d]. Post hoc (Tukey-Kramer) test indicated that ethanol
at the dose of 2 g/kg significantly decreased locomotor activ-
ity (P < 0.01) and coordination (P < 0.001). Thus, the results of
these experiments have shown that ethanol at the doses of 1.5
and 1.75 g/kg induced memory impairment in the Barnes
maze task without affecting locomotor activity and motor
coordination. Because our unpublished data indicated that
the ethanol dose of 1.5 g/kg affected only one parameter
(number of primary errors) tested in the Barnes maze, we
decided to apply a higher dose of ethanol (1.75 g/kg).
Experiment 2 Effect of donepezil, given before the probe trial
on spatial memory retrieval and cognitive flexibility impaired
by acute ethanol administration in the Barnes maze task
On the last day of acquisition (4th day, 1 day before ran-
domization), the average latency (basal primary latency) in
rats to reach the escape box (mean of three trials ± SEM) was
21.31 s ± 1.27 s.
During the probe trial on day 5, a two-way ANOVA showed
statistically significant differences between the groups in the
primary latency [treatment F(1,76) = 9.77, P < 0.01; dose of
donepezil F(2,76) = 5.81, P < 0.01; treatment × dose of
donepezil interaction F(2,76) = 14.96, P < 0.001; Fig. 3a] and
a number of primary errors [treatment F(1,76) = 25.94,
P < 0.001; dose of donepezil F(2,76) = 36.31, P < 0.001; treat-
ment × dose of donepezil interaction F(2,76) = 51.61,
P < 0.001; Fig. 3b]. Moreover, post hoc (Bonferroni) test re-
vealed that ethanol-treated rats showed statistically significant
increase in the primary latency (P < 0.001) and errors
(P < 0.001) committed to reach the escape box, as compared
to control animals. Donepezil, given before ethanol in the probe
trial, prevented/attenuated the short-time spatial memory im-
pairment induced by ethanol. Donepezil, at both doses (1 or
3 mg/kg, i.p.), decreased the primary latency (P < 0.01) and the



















































































































































































































Fig. 2 The influence of different doses of ethanol (1.5, 1.75, or 2 g/kg,
i.p.) on a primary latency; b number of errors measured during the probe
trial in the Barnes maze task; c locomotor activity; dmotor coordination.
Ethanol was given 30 min before all experiments. Results are expressed
as mean ± SEM. ***P < 0.001, **P < 0.01, *P < 0.05 vs. saline-treated
rats; (n = 7/group); EtOH ethanol, SAL saline
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Reversal learning trials were performed 1 h after the probe
trial. A two-way ANOVA showed significant effect of a dose
of donepezil [F(2,76) = 11.74, P < 0.001] and treatment × dose
of donepezil interaction [F(2,76) = 10.97, P < 0.001; Fig. 3c].
Moreover, a two-way ANOVA indicated statistically signifi-
cant differences between the groups in the number of primary
errors [treatment F(1,76) = 6.40, P < 0.05; dose of donepezil
F(2,76) = 10.17, P < 0.001; treatment × dose of donepezil in-
teraction F(2,76) = 9.48, P < 0.001; Fig. 3d]. Post hoc
(Bonferroni) test revealed a significant increase in the primary
latency (P < 0.001) and the number of primary errors
(P < 0.001) committed to reach the target hole in the ethanol-
treated group. Pretreatment with donepezil prevented the
cognitive flexibility impairment induced by ethanol.
Donepezil at the dose of 1 mg/kg (P < 0.01) or 3 mg/kg
(P < 0.001) decreased primary latency and, at these doses,
decreased a number of primary errors (P < 0.001) committed
to reaching the escape box in the ethanol-treated rats.
Experiment 3 Effect of rivastigmine, given before the probe
trial on spatial memory retrieval and cognitive flexibility im-
paired by acute ethanol administration in the Barnes maze task
On the last day of acquisition (4th day, 1 day before ran-
domization of animals), the average latency (basal primary
latency) to reach the escape box (mean of three trials ± SEM)
was 18.32 s ± 0.98 s.
During the probe trial on day 5, a two-way ANOVA
showed statistically significant differences between the groups
in the primary latency [treatment F(1,66) = 16.96, P < 0.001;
dose of rivastigmine F(2,66) = 4.74, P < 0.05; treatment × dose
of rivastigmine interaction F(2,66) = 16.00, P < 0.001; Fig. 4a]
and the number of primary errors [treatment F(1,66) = 19.75,
P < 0.001; dose of rivastigmine F(2,66) = 7.78, P < 0.01; treat-
ment × dose of rivastigmine interaction F(2,66) = 9.57,
P < 0.001; Fig. 4b]. Post hoc (Bonferroni) test indicated a sig-
nificant increase in the primary latency (P < 0.001) and the











































































































































































































































































Fig. 3 The influence of donepezil (1 or 3 mg/kg, i.p.) on the spatial
memory impairments caused by acute ethanol (1.75 g/kg, i.p.)
administration measured in the Barnes maze task in rats. Fifty minutes
prior the probe trial, rats received donepezil, followed by ethanol
(1.75 g/kg) or saline 20 min later (30 min before the probe trial).
Primary latency (panels a, c) and number of errors (panels b, d),
measured during the probe trial and reversal learning are shown as
mean ± SEM of the three trials (n = 13–14/group). ***P < 0.001 vs.
saline-treated rats; ^^P < 0.01; ^^^P < 0.001 vs. ethanol-treated rats.
DON donepezil
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in the ethanol-treated group. Rivastigmine, given before
ethanol in the probe trial, prevented the short-time memory
impairment induced by ethanol. Rivastigmine at both doses
(0.5 or 1 mg/kg, i.p.) decreased the primary latency
(P < 0.001) and the number of primary errors (P < 0.001) com-
mitted to reaching the escape box, in the ethanol-treated rats.
Reversal learning trials were performed 1 h after the probe
trial. A two-way ANOVA showed statistically significant
differences between the groups in the primary latency [treat-
ment F(1,66) = 13.60, P < 0.001; dose of rivastigmine
F(2,66) = 11.99, P < 0.001; treatment × dose of rivastigmine
interaction F(2,66) = 24.40, P < 0.001; Fig. 4c] and the num-
ber of primary errors [treatment F(1,66) = 8.35, P < 0.01; dose
of rivastigmine F(2,66) = 9.90, P < 0.001; treatment × dose of
rivastigmine interaction F(2,66) = 3.60, P < 0.05; Fig. 4d].
Post hoc (Bonferroni) test revealed an increase in the primary
latency (P < 0.001) and a higher number of errors committed
(P < 0.001) to reaching the escape box, in the ethanol-treated
group. Pretreatment with rivastigmine prevented the cognitive
flexibility impairment induced by ethanol. Rivastigmine, giv-
en prior to ethanol at both doses (1 and 3 mg/kg), decreased
the primary latency (P < 0.001) and the number of primary
errors (P < 0.001) to reaching the escape box.
Experiment 4 The influence of cholinesterase inhibitors,
given before the reversal learning on cognitive flexibility
impaired by ethanol administration before the probe trial in
the Barnes maze task
On the last day of acquisition (4th day, 1 day before ran-
domization of animals), the average latency (basal primary
latency) in rats to reaching the escape box (mean of three
trials ± SEM) was 20.99 ± 0.95 s.
In the probe trial (5th day), a one-way ANOVA [escape
latency F(5,66) = 6.37, P < 0.001, Fig. 5a; number of errors
F(5,66) = 6.33, P < 0.001, Fig. 5b] indicated that, unlike con-






























































































































































Fig. 4 The influence of rivastigmine (0.5 or 1 mg/kg, i.p.) on the spatial
memory impairments caused by acute ethanol (1.75 g/kg, i.p.)
administration measured during the Barnes maze task in rats. Fifty
minutes prior the probe trial, rats received rivastigmine followed by
ethanol (1.75 g/kg) or saline 20 min later (30 min before the
probe trial). Escape latency (panels a, c) and number of errors
(panels b, d) measured at the probe trial and reversal learning are
shown as mean ± SEM of the three trials (n = 12 group).
**P < 0.01; ***P < 0.001 vs. saline-treated rats; ^^^P < 0.001 vs.
ethanol-treated rats. RV rivastigmine
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location (escape latency P < 0.001; number of errors
P < 0.001) during the reversal phase, suggesting a loss of cog-
nitive flexibility. Both cholinesterase inhibitors attenuated
cognitive flexibility impairment induced by ethanol. Thus,
donepezil given before the reversal learning in the ethanol-
treated rats, only at the dose of 3 mg/kg, decreased primary
latency (P < 0.001) and the number of errors (P < 0.001). Both
doses of rivastigmine (0.5 or 1 mg/kg) given before the
reversal learning in the ethanol-treated rats decreased primary
latency and the number of errors (P < 0.001).
Experiment 5 Effect of donepezil and rivastigmine on loco-
motor activity and rotarod
A one-way ANOVA revealed that acute administration of
donepezil and rivastigmine alone disturbed neither locomotor
activity [F(4,33) = 1.02, P > 0.05] nor motor coordination
[F(4,33) = 0.42, P > 0.05] in rats (data not shown).
Discussion
The present study has shown that acute ethanol administration
before the probe trial (24 h after the last acquisition trial)
impaired spatial memory and cognitive flexibility in the
Barnes maze task. These ethanol effects were prevented by
pretreatment with the cholinesterase inhibitors, donepezil and
rivastigmine, given before ethanol in the probe trial.
Moreover, these cholinesterase inhibitors given before the re-
versal learning trials were capable of reversing the cognitive
flexibility impairments observed after ethanol administration
(before the probe trial) in this maze. Although we have not
observed differences in effectiveness of both cholinesterase
inhibitors in preventing ethanol-induced cognitive impair-
ments when these drugs were given before probe trial,
rivastigmine was more effective than donepezil when it was
given before the reversal learning, most probably due to its
broader inhibitory spectrum. Furthermore, both cholinesterase
inhibitors, given alone, did not affect locomotor activity and
motor coordination at the doses used in the Barnes maze task.
The reduction in hippocampal ACh levels specifically cor-
relates with impairments in the spatial memory (Ikegami
1994; Mishima et al. 2000; Gold 2003). Ethanol decreases
ACh release in the hippocampus (Henn et al. 1998) and may
impair spatial memory. The results of the present experiments
show that acute ethanol administration impaired the use of a
previously learned spatial reference memory task. In our
study, animals were first trained to navigate to the escape
shelter in the Barnes maze for 4 days and then (day 5) were
tested under one of three doses of ethanol (saline control, 1.5,
1.75, or 2.0 g/kg i.p. injection) for 30 min, following ethanol
administration. Ethanol produced a significant dose-
dependent impairment in the previously learned spatial infor-
mation. Thus, pretest administration of ethanol impaired the
retrieval of spatial memory on the test day, compared to saline-
treated animals. Furthermore, our experiments indicated that
the ethanol dose of 1.75 g/kg was Boptimal^ for the future
study, because it produced memory impairment in the
Barnes maze task without affecting locomotor activity and
motor coordination. The impairment of spatial memory was
confirmed by earlier reports. In these, acute ethanol adminis-
tration before the task on the test day impaired spatial learning
and memory in the water/radial maze in animals (Matthews
et al. 1995; White et al. 1998; Berry and Matthews 2004).
Systemic (oral) administration of the cholinesterase inhib-
itors, donepezil and rivastigmine, is known to increase extra-
cellular ACh concentration in the hippocampus and prefrontal
cortex (Liang and Tang 2006; Kosasa et al. 1999). In the





























































































































Fig. 5 The influence of donepezil (1 or 3 mg/kg, i.p.) and rivastigmine
(0.5 or 1 mg/kg, i.p.) on the ethanol-impaired cognitive flexibility in the
reversal learning during the Barnes maze task in rats. Ethanol (1.75 g/kg,
i.p.) was given 30 min before the probe trial, while donepezil or
rivastigmine were given 10 min after the probe trial (50 min before the
reversal learning trials). Primary latency (panel a) and number of errors
(panels b) measured during the reversal learning are shown as mean
± SEM of the three trials (n = 12/group). ***P < 0.001 vs. SAL/SAL
group of rats; ^^^P < 0.001 vs. EtOH/SAL group of rats
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and rivastigmine before ethanol prevented ethanol-induced
spatial memory deficits in the Barnes maze task. These data
may suggest that the cholinergic system is closely associated
with the spatial memory impairment that is induced by acute
ethanol administration. This is in agreement with several
investigations concerning memory, indicating an interaction
between ethanol and the cholinergic system in the laboratory
animals (Arendt 1994; Pick et al. 1993; Rezayof et al. 2008).
Reversal learning is a type of discrimination learning that
measures cognitive flexibility (Stalnaker et al. 2009), and
impairment of the reversal learning has been interpreted as
perseveration of behavior (Obernier et al. 2002). Previous ex-
periments have indicated that reversal learning is impaired
after acute ethanol in nonhuman primates (Jedema et al.
2011) and after ethanol binge in rats (Obernier et al. 2002;
Kuzmin et al. 2012). Our data extend these observations and
show, for the first time, that acute ethanol (1.75 g/kg) admin-
istration impaired reversal learning in the Barnes maze task in
rats. Previous studies have also established that chronic etha-
nol abuse impairs reversal performance and reduces
orbitofrontal cortex activity (Volkow et al. 1993; Volkow
and Fowler 2000; Fortier et al. 2008). Such effect of chronic
ethanol abuse has been correlated with a higher incidence of
relapse (Noël et al. 2002). In turn, acute effect of ethanol on
the orbitofrontal cortex may contribute to the impaired inhibi-
tion of prepotent responding and increased impulsivity that
presumably underlie poor decisions associated with
subintoxicating levels of ethanol (de Wit et al. 2000;
Dougherty et al. 2008). Our study revealed that cholinesterase
inhibitors given either before ethanol administration prior to
probe trial or before reversal learning trials improved reversal
learning processes. Furthermore, rivastigmine at both doses
(0.5 and 1 mg/kg, i.p.), but donepezil only at a higher dose
(3 mg/kg, i.p.), given prior to the reversal learning, reversed
the ethanol-induced impairment in cognitive flexibility. Thus,
rivastigmine appears to exert a more beneficial effect than
donepezil in reversing ethanol-induced cognitive impair-
ments, probably due to its wider spectrum of inhibitory activ-
ity. These data indicate the valuable effect of cholinesterase
inhibitors in cognitive disturbance induced by acute ethanol
administration.
Although ACh inhibitors counteracted ethanol-induced
impairment in spatial memory and cognition, the precise
mechanism of this phenomenon is not completely understood.
Ethanol is known to alter the activity of multiple signaling
molecules involved in synaptic processing in the brain
(Nevo and Hamon 1995; Diamond and Gordon 1997), includ-
ing activation of -aminobutyric acid-A (GABA-A) receptors
or blockade of N-methyl-D-aspartate (NMDA) glutamate re-
ceptors (Lovinger et al. 1990; Göthert and Fink 1989).
Moreover, ethanol effects on glutamate and GABA-A recep-
tors contribute to the ethanol-induced changes in long-term
potentiation (LTP) and long-term depression (LTD), two
forms of synaptic plasticity thought to underlie memory
acquisition (Zorumski et al. 2014). It has been indicated that
activation of GABAergic neurons negatively modulates cho-
linergic cell bodies in the septum (Imperato et al. 1993;
Giovannini et al. 1994), but activation of NMDA receptors
either stimulates or inhibits hippocampal ACh release
(Giovannini et al. 1998; Moor et al. 1996). Furthermore, glu-
tamatergic activation of the PFC by a direct input from the
hippocampus seems to be an essential part of the mechanisms
of spatial memory (Vickery et al. 1997; Lee and Kesner 2003).
Studies in rodents indicated that cholinergic stimulation facil-
itates the processing of incoming information. Application of
donepezil or rivastigmine generally elevates ACh levels and
thus affects both nicotinic (nAChRs) and muscarinic
(mAChRs) cholinergic receptors. In addition, activation of
nAChRs enhances excitatory input to the hippocampal
area CA3 from the entorhinal cortex (Giocomo and
Hasselmo 2005) and from dentate gyrus (Radcliffe et al.
1999); thus, this may enhance the efficiency of encoding
spatial information. In our study, both cholinesterase in-
hibitors facilitated acquisition of new information in the
reversal phase of the Barnes maze task.
There are few studies that have investigated the role of the
cholinergic system inmemory retrieval (Zarrindast et al. 1996;
Martí Barros et al. 2004; Soares et al. 2006; Piri and Zarrindast
2011). Our experiments extend these data and indicate that
pretreatment with cholinesterase inhibitors reduced the
ethanol-induced impairment in retrieval of spatial memory.
Such outcome suggests that ACh is necessary for recalling
the well-trained spatial memory disturbed by ethanol. It has
also been implied that well-trained memory (experimentally
experienced) is stored in the neocortex and retrieved by glu-
tamatergic top-down signals from the PFC (Hasegawa et al.
1998). Activation of mAChRs but not nAChRs in the cortical
regions is involved in this mechanism (Saper 1984). This
allows retrieving memory by regulating the dynamics of the
neuronal network in the glutamatergic system. The spatial
memory deficits induced by ethanol are correlated with the
decrease in glutamate output and might be accompanied by
the reduction in ACh transmission mediated by septal GABA
receptors in the hippocampus (Shimizu et al. 1998). Because
there is an interaction between PFC and hippocampus in
controlling memory retrieval (Preston and Eichenbaum
2013), prior administration of cholinesterase inhibitors to
alcohol intake may increase ACh level and prevent reduction
in glutamate output induced by ethanol. It seems that such
mechanism may be involved in the effects produced by
donepezil and rivastigmine on the impaired memory retrieval
induced by acute ethanol administration.
In conclusion, our study indicated, for the first time, that
cholinesterase inhibitors, donepezil and rivastigmine, prevent
impairment of short-term spatial memory and memory flexi-
bility induced by acute ethanol given after the acquisition
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phase in the Barnes maze task. Furthermore, both drugs
(donepezil only at higher dose) prevent the cognitive flexibil-
ity impairment induced by acute ethanol when given prior to
the reversal learning of the task. Thus, our data show that not
only is ACh beneficial in memory retrieval, following acute
ethanol impairment, but also is necessary for the improvement
of learning and memory disturbed by ethanol. Further studies
are required to elucidate the molecular mechanisms involved
in these effects.
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